Skip to main content

Biocon Limited (BIOCON)

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

BIOCON LIMITED. financial statements, including revenue, expenses, and profit: The total revenue of BIOCON for the last quarter is 44.17 B INR, and it's 15.59% higher compared to the previous quarter. The net income of Q4 24 is 3.44 B INR.

BIOCON LIMITED. dividends overview: BIOCON dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.13%.

BIOCON LIMITED. earnings per share and revenue: BIOCON earnings per share for the last quarter are 2.81 INR whereas the estimation was 1.39 INR which accounts for 102.25% surprise. Company revenue for the same period amounts to 44.17 B INR despite the estimated figure of 40.99 B INR. Estimated earnings per share for the next quarter are 0.71 INR, and revenue is expected to reach 39.78 B INR. Also watch annual changes over time to get a bigger picture of BIOCON earnings per share and revenue dynamics.

BIOCON LIMITED. revenue breakdown overview: BIOCON LIMITED. revenue for the last year amounted to 152.62 B INR, the most of which — 89.29 B INR — came from its highest performing source at the moment, Biosimilars, the year earlier bringing 88.18 B INR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOCON LIMITED. 70.42 B INR, and the year before that — 64.55 B INR.
Potential 50% Upside with Entry Price 350 Target Price 525, Timeframe 6-12 Months




Comments

Popular posts from this blog

Lemon Tree Hotels Limited (LEMONTREE)

Lemon Tree Hotels Ltd. owns and operates leisure hotels and resorts. It designs, develops, finances and manages hotels under its own brands include Lemon Tree Premier, Lemon Tree Hotels and Red Fox Hotels. The firm offers vacation packages that are ideal for families, couples and business travelers. The company was founded by Patanjali Govind Keswani on June 2, 1992 and is headquartered in New Delhi, India. LEMON TREE HOTELS LTD financial statements, including revenue, expenses, and profit: The total revenue of LEMONTREE for the last quarter is 3.16 B INR, and it's 16.58% lower compared to the previous quarter. The net income of Q1 25 is 383.31 M INR. LEMON TREE HOTELS LTD earnings per share and revenue: LEMONTREE earnings per share for the last quarter are 0.50 INR whereas the estimation was 0.53 INR which accounts for -6.25% surprise. Company revenue for the same period amounts to 3.12 B INR despite the estimated figure of 3.16 B INR. Also watch annual changes over time to get ...

Tata Steel Limited (TATASTEEL)

Tata Steel Ltd. is a holding company, which engages in the manufacture of iron and steel products. It operates through the following segments: Agriculture, Automotive Steels, Construction, Consumer Goods, Energy and Power, Engineering and Material Handling. Its products include Automotive Steels, Galvano, Tata Agrico, Astrum, Bearings, Pipes, Precision Tubes, Shaktee, Steelium, Tiscon and Wiron. The company was founded on August 26, 1907 and is headquartered in Mumbai, India. TATA STEEL LTD financial statements, including revenue, expenses, and profit: The total revenue of TATASTEEL for the last quarter is 531.78 B INR, and it's 5.41% lower compared to the previous quarter. The net income of Q1 25 is 20.78 B INR. TATA STEEL LTD key financial stats and ratios: TATASTEEL price-to-sales ratio is 0.91. The company has an Enterprise Value to EBITDA ratio of 7.49. As of 2024 they employed 80 k people. TATA STEEL LTD dividends overview: TATASTEEL dividends are paid annually. The last d...

Lloyds Metals & Energy Limited (LLOYDSME)

Lloyds Metals & Energy Ltd. engages in the manufacturing, generation, and distribution of iron, steel, and power. It operates through the following segments: Sponge Iron, Power, and Mining. The Sponge Iron segment includes production and manufacturing of sponge iron. The Power segment refers to the extraction of iron ore from mines. The Mining segment focuses on the generation of power. The company was founded by Babulal Kesardeo Agarwal and Rajesh Rajnarayan Gupta on April 5, 1977 and is headquartered in Mumbai, India. LLOYDS METALS N ENERGY L financial statements, including revenue, expenses, and profit: The total revenue of LLOYDSME for the last quarter is 11.93 B INR, and it's 28.77% lower compared to the previous quarter. The net income of Q4 24 is 2.02 B INR. LLOYDS METALS N ENERGY L key financial stats and ratios: LLOYDSME price-to-sales ratio is 11.90. The company has an Enterprise Value to EBITDA ratio of 39.56. As of 2024 they employed 2.37 k people. LLOYDS METALS N...